跳至主要内容
临床试验/NCT04989764
NCT04989764已完成不适用

COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY ON OUTCOMES OF OPERABLE GASTRIC CANCER: EXPERIENCE FROM A CANCER CARE CENTER

Shaukat Khanum Memorial Cancer Hospital & Research Centre0 个研究点目标入组 108 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
108
主要终点
The overall survival

研究概览

简要总结

  • Patients with gastric adenocarcinoma
  • Comparison: perioperative chemotherapy vs. adjuvant therapy.
  • Sample size differences between the two groups.
  • Kaplan meier survival analysis, overall survival and disease free survival

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

接受健康志愿者

入选标准

  • We included histologically proven gastric adenocarcinoma patient with operable disease and the patients who completed their prescribed perioperative or adjuvant chemotherapy cycles

排除标准

  • Patients were excluded if they had Tis or T1, N0 disease, inoperable disease, metastatic. In addition, all those who did not undergo adequate lymphadenectomy (< D2) or had R1 margins following surgery were excluded

结局指标

主要结局

The overall survival

时间窗: from January 2015 till December 2019

The overall survival (OS) was defined as the length of the time from date of diagnosis till last follow-up or death

The disease-free survival

时间窗: from January 2015 till December 2019

The disease free survival (DFS) as the length of the time from date of last treatment which is either perioperative or adjuvant chemotherapy to tumor relapse or death.

次要结局

未报告次要终点

研究者

发起方
Shaukat Khanum Memorial Cancer Hospital & Research Centre
申办方类型
Other
责任方
Sponsor

相似试验